News
Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs. First ...
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund (MINT) Dividend History ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback